AI-Powered Precision Decision-Making for Pancreatic Diseases
Recruiting
Observational Study
Pancreatic Cancer
Diagnose Disease
IPMN, Pancreatic
Pancreatic Cystic Lesions
Chronic Pancreatitis
Pancreatic Neuroendocrine Tumor
Acute Pancreatitis (AP)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Changhai Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter clinical trial evaluates an artificial intelligence (AI) system designed to assist in the diagnosis and management of pancreatic diseases. Using contrast-enhanced CT scans, the study compares the AI's recommendations against the decisions of experienced clinicians to verify the system's accuracy and safety in a real-world setting. Patients are categorized into three management gro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinically suspected pancreatic disease.
* Scheduled to undergo contrast-enhanced CT.
* Signed informed consent form indicating agreement to participate.
Exclusion Criteria:
* History of pancreatic surgery.
* Contraindications to contrast-enhanced CT, including known hyperse…
Contacts